Clinical Trials
46 trialsCINC424A2X01B Rollover Protocol
Novartis
Pediatric Long-Term Follow-up and Rollover Study
Novartis
Asciminib Roll-over Study
Novartis
HU-F-AIM
Novartis
ASC4INDIA
Novartis
Avapritinib Rollover Study
Blueprint Medicines Corporation
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
The First Affiliated Hospital of Soochow University
ROPEG
Eulji University Hospital
PV
PharmaEssentia
Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
A Rollover Study to Provide Continued Treatment With Eltrombopag
Novartis
Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP
Shenzhen Second People's Hospital
NILOdeepR
Novartis
A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd.
SUSTRENIM
Gruppo Italiano Malattie EMatologiche dell'Adulto
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Pfizer
RUE-DDGP
Zhengzhou University
MACS0999
Novartis
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Phoenix Children's Hospital
King's Invasive Aspergillosis Study II
King's College Hospital NHS Trust
Crescendo
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
Celgene
ISAV
University of Milano Bicocca
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
IDEAL
Dong-A ST Co., Ltd.
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center
Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia
Hospital Universitario Dr. Jose E. Gonzalez
MACS1881
Novartis
NISRI
King Abdullah International Medical Research Center
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
H. Lee Moffitt Cancer Center and Research Institute
Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)
Novartis
MACS0439
Novartis
Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial
Novartis
Glivec in Pediatric Chronic Myeloid Leukemia (CML)
Poitiers University Hospital
Imatinib in KIT-negative Systemic Mastocytosis
Hospital Virgen de la Salud
MACS0911
Novartis
MACS1428
Novartis
Multicenter, Phaseâ…£, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib
Samsung Medical Center
Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia
Cttq
Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
PIMERIndia
DFMBHSCT
The First Affiliated Hospital of Soochow University
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)
Tel-Aviv Sourasky Medical Center
Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Novartis
GIST
University Health Network, Toronto
Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
PETHEMA Foundation
FLAG-IDA
PETHEMA Foundation